TCI Wealth Advisors’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,077
Closed -$3.76K 2615
2022
Q4
$3.76K Buy
+1,077
New +$3.76K ﹤0.01% 1717